Clinical Trials for Blue Earth Diagnostics

Explore 20 clinical trials worldwide

Showing 1-20 of 20 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Blue Earth Diagnostics

Clinical Trials (20)

NCT07185165
An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
PHASE2Not yet recruiting
81 participants
Started: Sep 30, 2025 · Completed: Aug 25, 2036
1 condition2 sponsors1 location
NCT07164027
Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
EARLY_PHASE1Not yet recruiting
30 participants
Started: Sep 28, 2025 · Completed: Sep 28, 2036
1 condition2 sponsors1 location
NCT06862856
Flotufolastat F 18 PET in Men with Very Low PSA Recurrence
N/ANot yet recruiting
50 participants
Started: May 20, 2025 · Completed: Dec 1, 2026
2 conditions2 sponsors2 locations
NCT05555550
Evaluation of 18F-Fluciclovine Positron Emission Tomography - Magnetic Resonance Imaging (PET-MRI) in LGG
EARLY_PHASE1Recruiting
30 participants
Started: Apr 29, 2025 · Completed: Sep 30, 2027
5 conditions3 sponsors1 location
NCT06015295
A Pilot Study to Assess the Clinical Utility of 18F-Fluciclovine (Axumin) PET-CT for Detecting True-versus Pseudo-Progression of Brain Metastases on Immunotherapy
NARecruiting
20 participants
Started: Nov 7, 2024 · Completed: Mar 30, 2028
1 condition2 sponsors1 location
NCT06617481
PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence
PHASE2Recruiting
30 participants
Started: Sep 20, 2024 · Completed: Oct 10, 2027
1 condition2 sponsors1 location
NCT06055790
Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis
PHASE2Recruiting
20 participants
Started: Sep 10, 2024 · Completed: Oct 31, 2026
1 condition2 sponsors1 location
NCT06479187
PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer
PHASE4Recruiting
20 participants
Started: Jun 30, 2024 · Completed: Jun 20, 2027
3 conditions3 sponsors2 locations
NCT06048094
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
PHASE1Recruiting
46 participants
Started: Apr 11, 2024 · Completed: May 31, 2027
3 conditions2 sponsors1 location
NCT06062745
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
PHASE1Recruiting
30 participants
Started: Feb 1, 2024 · Completed: Sep 1, 2028
3 conditions2 sponsors2 locations
NCT06159335
18F-FLUC PET/MR in Patients With Brain Mets
PHASE3Recruiting
30 participants
Started: Jan 10, 2024 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05722925
Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET
PHASE4Active, not recruiting
50 participants
Started: Oct 4, 2023 · Completed: Jan 1, 2026
1 condition3 sponsors1 location
NCT05553041
18F-Fluciclovine PET-MRI in High-grade Glioma
EARLY_PHASE1Recruiting
30 participants
Started: Aug 7, 2023 · Completed: Dec 31, 2026
5 conditions3 sponsors1 location
NCT05779943
Comparison of 18F-rhPSMA-7.3 PET/CT With and Without Furosemide in Biochemical Recurrence of Prostate Cancer
PHASE2Active, not recruiting
20 participants
Started: Apr 27, 2023 · Completed: Jul 1, 2028
2 conditions3 sponsors4 locations
NCT05799248
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
PHASE3Recruiting
113 participants
Started: Apr 27, 2023 · Completed: May 28, 2024
1 condition2 sponsors1 location
NCT05678322
Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy
PHASE3Active, not recruiting
26 participants
Started: Jan 31, 2023 · Completed: Nov 30, 2025
1 condition2 sponsors1 location
NCT05554302
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
PHASE2Recruiting
20 participants
Started: Jan 10, 2023 · Completed: Jan 31, 2030
2 conditions2 sponsors1 location
NCT04689048
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
PHASE1Recruiting
20 participants
Started: Apr 4, 2022 · Completed: Dec 31, 2026
3 conditions2 sponsors1 location
NCT04175431
Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study
PHASE2Recruiting
100 participants
Started: Sep 30, 2020 · Completed: Jul 1, 2031
1 condition2 sponsors2 locations
NCT04018053
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
EARLY_PHASE1Active, not recruiting
16 participants
Started: Feb 26, 2020 · Completed: Dec 30, 2025
2 conditions2 sponsors1 location